About Dylan Smith

This author has not yet filled in any details.
So far Dylan Smith has created 43 blog entries.

New Updates to Aculabs Online Order Entry System

As an industry leader, Aculabs values the way in which our digital and technological systems can always be improved to continually optimize the user experience. Our Online Web Portal remains the main hub for which many clients can 1) most easily place orders and 2) receive order results in the shortest time possible, necessary

By |2022-01-06T12:36:54-05:00January 6th, 2022|Categories: News|0 Comments

FDA Warns of Reduced Sensitivity for Omicron in Rapid Tests

In a new memo, the United States Food & Drug Administration (FDA) has documented and warned both patients and healthcare providers of the risk of Omicron, the latest variant of SARS-CoV-2, displaying reduced sensitivity to rapid antigen tests. Rapid antigen tests, sometimes referred to as lateral flow tests, are often used in occupational and

By |2021-12-29T11:19:27-05:00December 29th, 2021|Categories: News|0 Comments

CDC Warns of Supply Shortage for COVID-19 Rapid Tests

In a recent newsletter announcement, the Centers for Disease Control and Prevention warned of a shortage occurring for COVID-19 rapid tests. In this advisory, the CDC advised diagnostic service providers to expect an increase in the demand for laboratory-based COVID-19 testing due to a shortage in supply for both point-of-care testing and rapid testing

By |2021-10-29T12:54:39-04:00September 2nd, 2021|Categories: News|0 Comments

NJ DOH issues guidance for SARS-CoV-2 positive specimen in cases of vaccine breakthrough and reinfection

The New Jersey Department of Health has asked for all healthcare providers and long-term care facilities in the state to alert them of SARS‐CoV‐2 positive respiratory specimens when vaccine failure is suspected so that genomic sequencing can be performed. Per the guidance: “Because most commercial laboratories retain respiratory specimens only a couple days, once

By |2021-10-29T13:00:46-04:00July 16th, 2021|Categories: News|0 Comments

Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic

Respiratory tract infection is one of the most frequent and fatal infections in the geriatric population. Long-term Care Facilities (LTCF) residents are prone to infection because of the decrease in their immunity, their impaired cognitive function, frailty, congregated setting, the kinds of medication taken, and the presence of many underlying factors like diabetes or

By |2021-10-29T13:08:21-04:00July 7th, 2021|Categories: Quarterly Letter|Comments Off on Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic

CAP ranks Aculabs as Deficiency-Free in 2021 Inspection

During the week of Monday, May 10th, 2021, Aculabs was happy to open our doors to be inspected for continued accreditation by representatives from The College of American Pathologists. The College of American Pathologists describes its accreditation curriculum as follows on its website: The College of American Pathologists (CAP's) Laboratory Accreditation Program accredits the entire spectrum

By |2021-10-29T15:21:26-04:00May 28th, 2021|Categories: News|0 Comments

New Jersey OEM Extends Expiration Date on BinaxNOW Cards

Over the course of the last six months, Aculabs has helped the New Jersey Department of Health by assisting with the distribution of the BinaxNOWTM COVID-19 Ag test cards. Throughout the pilot program, Aculabs has helped to distribute over 1 Million of the test cards on behalf of the New Jersey Department of Health's Office

By |2021-03-10T10:18:08-05:00March 9th, 2021|Categories: News|0 Comments

Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production

Published December 2020 as part of Aculabs’ LabTalk quarterly newsletter. Aculabs will be offering a Reticulocyte Comprehensive Panel – the panel can provide comprehensive information needed by physicians to assess the rate of red cell production and hemoglobinization. Reticulocyte count (RET #, %) indicates the quantity of circulating reticulocytes. The Immature Reticulocyte Fraction (IRF) indicates

By |2021-10-29T15:31:42-04:00December 29th, 2020|Categories: Quarterly Letter|Comments Off on Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production

Letter from the Director: Understanding Antibody Testing Provided by Aculabs

Antibodies are proteins produced by the immune system in response to infection, often within the first week of post-symptoms onset. There are several forms of antibodies: IgG, IgM, IgA, as well as other forms. However, not all antibodies are created equal; some are considered to be binding antibody and some are neutralizing. A neutralizing

By |2021-01-26T10:25:55-05:00December 29th, 2020|Categories: Quarterly Letter|Comments Off on Letter from the Director: Understanding Antibody Testing Provided by Aculabs
Go to Top